Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 1782835, 7 pages
http://dx.doi.org/10.1155/2016/1782835
Research Article

Emerging Perils of Extended Spectrum β-Lactamase Producing Enterobacteriaceae Clinical Isolates in a Teaching Hospital of Nepal

1Department of Laboratory Medicine, Manmohan Memorial Medical College and Teaching Hospital, Kathmandu, Nepal
2Department of Clinical Microbiology, Manmohan Memorial Medical College and Teaching Hospital, Kathmandu, Nepal

Received 12 September 2016; Accepted 15 December 2016

Academic Editor: Frederick Adzitey

Copyright © 2016 Narayan Prasad Parajuli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. D. Pitout and K. B. Laupland, “Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern,” The Lancet Infectious Diseases, vol. 8, no. 3, pp. 159–166, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Doi, Y. S. Park, J. I. Rivera et al., “Community-associated extended-spectrum beta-lactamase-producing Escherichia coli infection in the United States,” Clinical Infectious Diseases, vol. 56, no. 5, pp. 641–648, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Brolund, “Overview of ESBL-producing Enterobacteriaceae from a Nordic perspective,” Infection Ecology & Epidemiology, vol. 4, pp. 1–9, 2014. View at Publisher · View at Google Scholar
  4. M. J. Schwaber and Y. Carmeli, “Mortality and delay in effective therapy associated with extended-spectrum β-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis,” Journal of Antimicrobial Chemotherapy, vol. 60, no. 5, pp. 913–920, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Karisik, M. J. Ellington, R. Pike, R. E. Warren, D. M. Livermore, and N. Woodford, “Molecular characterization of plasmids encoding CTX-M-15 β-lactamases from Escherichia coli strains in the United Kingdom,” Journal of Antimicrobial Chemotherapy, vol. 58, no. 3, pp. 665–668, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. D. M. Livermore, “Current epidemiology and growing resistance of Gram-negative pathogens,” Korean Journal of Internal Medicine, vol. 27, no. 2, pp. 128–142, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. D. L. Paterson and R. A. Bonomo, “Extended-spectrum β-lactamases: a clinical update,” Clinical Microbiology Reviews, vol. 18, no. 4, pp. 657–686, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. É. Ruppé, P.-L. Woerther, and F. Barbier, “Mechanisms of antimicrobial resistance in Gram-negative bacilli,” Annals of Intensive Care, vol. 5, article 21, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. J. B. Sherchan, K. Hayakawa, T. Miyoshi-Akiyama et al., “Clinical epidemiology and molecular analysis of extended-spectrum-β-lactamase-producing Escherichia coli in Nepal: characteristics of sequence types 131 and 648,” Antimicrobial Agents and Chemotherapy, vol. 59, no. 6, pp. 3424–3432, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. R. H. Pokhrel, B. Thapa, R. Kafle, P. K. Shah, and C. Tribuddharat, “Co-existence of beta-lactamases in clinical isolates of Escherichia coli from Kathmandu, Nepal,” BMC Research Notes, vol. 7, article 694, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. D. M. Livermore, J. M. Andrews, P. M. Hawkey et al., “Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?” Journal of Antimicrobial Chemotherapy, vol. 67, no. 7, pp. 1569–1577, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Drieux, F. Brossier, W. Sougakoff, and V. Jarlier, “Phenotypic detection of extended-spectrum β-lactamase production in Enterobacteriaceae: review and bench guide,” Clinical Microbiology and Infection, vol. 14, no. 1, pp. 90–103, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Sharma, S. Pathak, and P. Srivastava, “Prevalence and antibiogram of Extended Spectrum β-lactamase (ESBL) producing Gram negative bacilli and further molecular characterization of ESBL producing Escherichia coli and Klebsiella spp,” Journal of Clinical and Diagnostic Research, vol. 7, no. 10, pp. 2173–2177, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Kaur and A. Aggarwal, “Occurrence of the CTX-M, SHV and the TEM genes among the extended spectrum β-lactamase producing isolates of enterobacteriaceae in a tertiary care hospital of north India,” Journal of Clinical and Diagnostic Research, vol. 7, no. 4, pp. 642–645, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. H. D. Isenberg, Clinical Microbiology Procedure Handbook, ASM Press, Washington, DC, USA, 2nd edition, 2004.
  16. Performance Standards for Antimicrobial Disk Susceptibility Tests 2012, M02-A11(Approved Standard—Eleventh Edition), Clinical and Laboratory Standards Institute, Wayne, Pa, USA, 2012.
  17. A.-P. Magiorakos, A. Srinivasan, R. B. Carey et al., “Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance,” Clinical Microbiology and Infection, vol. 18, no. 3, pp. 268–281, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Chander and C. D. Shrestha, “Prevalence of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae urinary isolates in a tertiary care hospital in Kathmandu, Nepal,” BMC Research Notes, vol. 6, no. 1, article no. 487, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Neupane, N. D. Pant, S. Khatiwada, R. Chaudhary, and M. R. Banjara, “Correlation between biofilm formation and resistance toward different commonly used antibiotics along with extended spectrum beta lactamase production in uropathogenic Escherichia coli isolated from the patients suspected of urinary tract infections visiting Shree Birendra Hospital, Chhauni, Kathmandu, Nepal,” Antimicrobial Resistance and Infection Control, vol. 5, article 5, 2016. View at Publisher · View at Google Scholar
  20. S. Ansari, H. P. Nepal, R. Gautam et al., “Community acquired multi-drug resistant clinical isolates of Escherichia coli in a tertiary care center of Nepal,” Antimicrobial Resistance and Infection Control, vol. 4, no. 1, article no. 15, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Khanal, D. R. Joshi, D. R. Bhatta, U. Devkota, and B. M. Pokhrel, “β-lactamase-producing multidrug-resistant bacterial pathogens from tracheal aspirates of intensive care unit patients at national institute of neurological and allied sciences, Nepal,” ISRN Microbiology, vol. 2013, Article ID 847569, 5 pages, 2013. View at Publisher · View at Google Scholar
  22. K. K. Yadav, N. Adhikari, R. Khadka, A. D. Pant, and B. Shah, “Multidrug resistant Enterobacteriaceae and extended spectrum β-lactamase producing Escherichia coli: a cross-sectional study in National Kidney Center, Nepal,” Antimicrobial Resistance and Infection Control, vol. 4, article 42, 2015. View at Publisher · View at Google Scholar
  23. N. D. Pant, R. Bhandari, A. Poudel, and M. Sharma, “Assessment of the effectiveness of three different cephalosporins/clavulanate combinations for the phenotypic confirmation of extended spectrum beta lactamases producer bacterial isolates from urine samples at National Public Health Laboratory, Kathmandu, Nepal,” BMC Research Notes, vol. 9, article 390, 2016. View at Google Scholar
  24. Y.-Z. Yan, K.-D. Sun, L.-H. Pan et al., “A screening strategy for phenotypic detection of carbapenemase in the clinical laboratory,” Canadian Journal of Microbiology, vol. 60, no. 4, pp. 211–215, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Shanthi and U. Sekar, “Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes,” Journal of Association of Physicians of India, vol. 58, supplement, pp. 41–44, 2010. View at Google Scholar · View at Scopus
  26. S. Babypadmini and B. Appalaraju, “Extended spectrum β-lactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae—prevalence and susceptibility pattern in a tertiary care hospital,” Indian Journal of Medical Microbiology, vol. 22, no. 3, pp. 172–174, 2004. View at Google Scholar · View at Scopus
  27. A. Moses, F. Bwanga, Y. Boum, and J. Bazira, “Prevalence and genotypic characterization of extended- spectrum beta-lactamases produced by gram negative bacilli at a tertiary care hospital in Rural South Western Uganda,” British Microbiology Research Journal, vol. 4, no. 12, pp. 1541–1550, 2014. View at Publisher · View at Google Scholar
  28. P. Kiratisin, A. Apisarnthanarak, C. Laesripa, and P. Saifon, “Molecular characterization and epidemiology of extended-spectrum-β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic,” Antimicrobial Agents and Chemotherapy, vol. 52, no. 8, pp. 2818–2824, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. E. B. Bali, L. Açik, and N. Sultan, “Phenotypic and molecular characterization of SHV, TEM, CTX-M and extended-spectrum β-lactamase produced by Escherichia coli, Acinobacter baumannii and Klebsiella isolates in a Turkish hospital,” African Journal of Microbiology Research, vol. 4, no. 8, pp. 650–654, 2010. View at Google Scholar · View at Scopus
  30. D. M. Livermore, R. Canton, M. Gniadkowski et al., “CTX-M: changing the face of ESBLs in Europe,” Journal of Antimicrobial Chemotherapy, vol. 59, no. 2, pp. 165–174, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Bonnet, “Growing group of extended-spectrum β-lactamases: the CTX-M enzymes,” Antimicrobial Agents and Chemotherapy, vol. 48, no. 1, pp. 1–14, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Goyal, K. N. Prasad, A. Prasad, S. Gupta, U. Ghoshal, and A. Ayyagari, “Extended spectrum β-lactamases in Escherichia coli & Klebsiella pneumoniae & associated risk factors,” Indian Journal of Medical Research, vol. 129, no. 6, pp. 695–700, 2009. View at Google Scholar · View at Scopus